Heart attack not a death sentence

Jul 18, 2008

Survivors of cardiac arrest who received intensive care can expect long-term quality of life at reasonable expense to the health care system. Research published today in BioMed Central's open access journal Critical Care is the first to show that the allocation of resources to the treatment of heart attack patients is equally as justified as the treatment of other intensive care patient groups.

More than 600,000 people in Europe suffer cardiac arrest each year. Following successful CPR, patients are routinely admitted to intensive care units (ICUs). Although ICUs only care for a minority of patients, they consume a large proportion of hospital budgets.

The lead author of the study, Juergen Graf from the Philipps-University Marburg, Germany, said, "economic constraints create pressure to ration ICU care. Restricting the demand for futile medical services by limiting access to the ICU, at least for those patients likely to die anyway, has been proposed as a way of lowering expenditures".

In order to investigate this, Graf and his colleagues conducted an assessment of health status of patients five years after discharge from the ICU of Medical Clinic I, University Hospital Aachen, and combined this with a fully costed economic evaluation. Of 354 patients admitted to the ICU with cardiac arrest, 204 died prior to discharge from the hospital. Of the 150 remaining, 40 died before year five, leaving 110 patients (31%) eligible for the survey. The total costs for the ICU treatment of all 354 patients amounted to more than 6.3million euros.

According to Graf, "This is approximately double the cost of an average ICU patient, but it does compare favorably to a variety of other routine interventions such as mechanical ventilation or kidney dialysis". Furthermore, patients who survived cardiac arrest do not necessarily have as bleak a prognosis as is often anticipated. As the authors explain, "The health-related quality of life five years after discharge was only slightly lower than healthy controls of the same age and gender of the patients".

Graf concludes, "Our study is the first to demonstrate that patients who survive cardiac arrest without severe neurological disabilities may expect fair long-term survival and a good quality of life for reasonable expenses to the health care system".

Source: BioMed Central

Explore further: UN implores all countries to help on Ebola

add to favorites email to friend print save as pdf

Related Stories

FDA gives green light to RP-VITA hospital robot

Jan 25, 2013

(Phys.org)—The FDA has approved RP-VITA from iRobot and InTouch Health. This is an autonomous medical robot which will be able to make its rounds of hospital corridors in the U.S. within the next few months. ...

Recommended for you

UN implores all countries to help on Ebola

20 minutes ago

The international group Doctor Without Borders warned Tuesday that the world is 'losing the battle' against Ebola, while U.N. officials implored all countries to quickly step up their response by contributing health experts ...

Travel restrictions could worsen Ebola crisis: experts

4 hours ago

Travel restrictions could worsen West Africa's Ebola epidemic, limiting medical and food supplies and keeping out much-needed doctors, virologists said Tuesday as the disease continued its deadly spread.

World 'losing battle' to contain Ebola: MSF (Update)

5 hours ago

International medical agency Medecins sans Frontieres said Tuesday the world was "losing the battle" to contain Ebola as the United Nations warned of severe food shortages in the hardest-hit countries.

Mutating Ebola viruses not as scary as evolving ones

6 hours ago

My social media accounts today are cluttered with stories about "mutating" Ebola viruses. The usually excellent ScienceAlert, for example, rather breathlessly informs us "The Ebola virus is mutating faster in humans than in animal hosts ...

War between bacteria and phages benefits humans

6 hours ago

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages. In a new study, researchers from Tufts University, Massachusetts ...

User comments : 0